These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25652036)

  • 21. A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.
    Geyer MB; Jacobson JS; Freedman J; George D; Moore V; van de Ven C; Satwani P; Bhatia M; Garvin JH; Bradley MB; Harrison L; Morris E; Della-Latta P; Schwartz J; Baxter-Lowe LA; Cairo MS
    Br J Haematol; 2011 Oct; 155(2):218-34. PubMed ID: 21848882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
    Martino R; Rovira M; Carreras E; Solano C; Jorge S; De La Rubia J; Caballero MD; de Oteyza JP; Zuazu J; Moraleda JM; Ojeda E; Ferrá C; Serrano D; De La Cámara R; Urbano-Ispízua A; Brunet S;
    Haematologica; 2001 Oct; 86(10):1075-86. PubMed ID: 11602414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
    Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
    Kusumi E; Kami M; Kanda Y; Murashige N; Seki K; Fujiwara M; Koyama R; Komatsu T; Hori A; Tanaka Y; Yuji K; Matsumura T; Masuoka K; Wake A; Miyakoshi S; Taniguchi S
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1302-9. PubMed ID: 17162212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies.
    Konuma T; Ooi J; Nagayama H; Tomonari A; Tsukada N; Kato S; Kawakita T; Isobe M; Monna-Oiwa M; Tojo A; Iseki T; Takahashi S
    Ann Hematol; 2022 Jan; 101(1):177-189. PubMed ID: 34591162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-Thaw Viable CD45+ Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant Diseases.
    Castillo N; García-Cadenas I; Barba P; Martino R; Azqueta C; Ferrà C; Canals C; Sierra J; Valcárcel D; Querol S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2167-2172. PubMed ID: 26319094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.
    Anand S; Thomas S; Corbet K; Gasparetto C; Long GD; Lopez R; Morris AK; Rizzieri DA; Sullivan KM; Sung AD; Sarantopoulos S; Chao NJ; Horwitz ME
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1949-1954. PubMed ID: 28729147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.
    Mikulska M; Raiola AM; Bruzzi P; Varaldo R; Annunziata S; Lamparelli T; Frassoni F; Tedone E; Galano B; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):92-9. PubMed ID: 21689774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
    Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Adults.
    Le Bourgeois A; Peterlin P; Guillaume T; Delaunay J; Duquesne A; Le Gouill S; Moreau P; Mohty M; Campion L; Chevallier P
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1473-1479. PubMed ID: 27118570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).
    Esquirol A; Querol S; Garcia-Cadenas I; Novelli S; Garrido A; Saavedra S; Moreno C; Granell M; Caballero A; Brunet S; Briones J; Martino R; Sierra J
    Ann Hematol; 2020 Jan; 99(1):157-165. PubMed ID: 31844931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
    Russell JA; Turner AR; Larratt L; Chaudhry A; Morris D; Brown C; Quinlan D; Stewart D
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):299-306. PubMed ID: 17317583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias.
    Bunin N; Aplenc R; Grupp S; Pierson G; Monos D
    Bone Marrow Transplant; 2006 Jan; 37(2):143-9. PubMed ID: 16284615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
    Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP
    Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.